Username Password
S&P 500: 1,349.74 Change: +0.07%

GENOMIC HEALTH INC (GHDX)

Overview
Price 26.18
Price Change Today -$0.39 (-1.47%)
P&P rating Rating: 5
Zacks Rank 3 - HOLD
Open Price $26.48
Previous Close $26.57
Daily Range $25.91 - $26.91
52-Week Range $19.00 - $29.52
Volume 513,200
chart
Genomic Health, Inc. is a life science company focused on the development and commercialization of genomic-based clinical diagnostic tests for cancer that allow physicians and patients to make individualized treatment decisions. It launched its first test, Oncotype DX, which has been shown to predict the likelihood of breast cancer recurrence and chemotherapy benefit in early stage breast cancer patients. The Oncotype DX assay represents the first diagnostic gene expression test on the market that provides consistent results across multiple independent trials having breast cancer patients, including a large validation study of The New England Journal of Medicine.
Other Resources for GHDX
zacks.com
Commentary
Zacks Blog: Genomic Misses, Grows Annually
February 7, 2012
Zacks Blog: Myriad Beats, Raises Guidance
February 1, 2012
Zacks Blog: Genomic's Useful Colon Cancer Test
January 23, 2012
Zacks Blog: Myriad Gets Rights to RAD51C Gene
January 19, 2012
Zacks Blog: Genomic Looks to Diversify Offering (revised)
January 11, 2012
Genomic Health, Inc. is a life science company focused on the development and commercialization of genomic-based clinical diagnostic tests for cancer that allow physicians and patients to make individualized treatment decisions. It launched its first test, Oncotype DX, which has been shown to predict the likelihood of breast cancer recurrence and chemotherapy benefit in early stage breast cancer patients. The Oncotype DX assay represents the first diagnostic gene expression test on the market that provides consistent results across multiple independent trials having breast cancer patients, including a large validation study of The New England Journal of Medicine.
 
Brokerage Analyst Recommendations
16 Brokerage Firms Covering GHDX
 
   
Strong Buy
5
Buy
0
Hold
9
Sell
0
Strong Sell
2
Average Broker Recommendation (ABR): 2.63
 
GHDX Ratings:BUY  SELL  HOLD
GHDX Consensus Forecasts
Rate this Stock!
You haven't rated this stock yet!

What The Community Thinks

Total Players

7 Buy
0 Sell
 
Top Buy Analysis
BUY: GHDX Rating: 5
Company: GENOMIC HEALTH INC.
Points: -3.81
Start Price: $18.01
Start Date: 05/20/2009 8:01 AM
supratrade1
supratrade1
P&P Score: 99.71
Recs:
-4.06% per week

Comments: 0 | Comment


Top Sell Analysis
No Sell Analysis. Be the First.
Blog Posts
User User Score Date Title Comments Last Comment
rjm77me
99.92 03/05/11 Insider buys and sells for week 0
Zacks_Analysts
0.00 02/07/12 Genomic Misses, Grows Annually - Analyst Blog 0
Zacks_Analysts
0.00 02/01/12 Myriad Beats, Raises Guidance - Analyst Blog 0
Zacks_Analysts
0.00 01/23/12 Genomic's Useful Colon Cancer Test - Analyst Blog 0
Zacks_Analysts
0.00 01/19/12 Myriad Gets Rights to RAD51C Gene - Analyst Blog 0
Zacks_Analysts
0.00 01/11/12 Genomic Looks to Diversify Offering (revised) - Analyst Blog 0
Zacks_Analysts
0.00 01/10/12 Genomic Looks to Diversify Offering - Analyst Blog 0
Zacks_Analysts
0.00 12/28/11 Myriad Reverts to Neutral - Analyst Blog 0
Zacks_Analysts
0.00 12/15/11 Myriad Bracanalysis Proves Cheaper - Analyst Blog 0
Zacks_Analysts
0.00 12/07/11 Genomic DCIS Score Coming Shortly - Analyst Blog 0
Pages: [ 1 ]  2   3   4   5  >>
Commentary
BUY: GENOMIC HEALTH INC. (GHDX) Rating: 5
Start Price: $26.59
Points: -8.42
Created: 11/07/2011
They are on a roll!

Comments: 0 | Comment

Recs:
 
BUY: GENOMIC HEALTH INC. (GHDX) Rating: 5
Start Price: $26.12
Points: -0.70
Created: 04/25/2011
Good looking long term chart

Comments: 0 | Comment

Recs:
 
BUY: GENOMIC HEALTH INC. (GHDX) Rating: 5
Start Price: $18.01
Points: -3.81
Created: 05/20/2009
-4.06% per week

Comments: 0 | Comment

Recs:
 
BUY: GENOMIC HEALTH INC. (GHDX) Rating: 5
Start Price: $17.55
Points: +57.46
Created: 01/01/2008

Comments: 0 | Comment

Bob Bob
Recs:
 
BUY: GENOMIC HEALTH INC. (GHDX) Rating: 5
Start Price: $22.17
Points: +26.32
Created: 01/01/2008

Comments: 0 | Comment

Recs:
 
BUY: GENOMIC HEALTH INC. (GHDX) Rating: 5
Start Price: $17.68
Points: +56.36
Created: 01/01/2008

Comments: 0 | Comment

Recs:
 
BUY: GENOMIC HEALTH INC. (GHDX) Rating: 5
Start Price: $19.22
Points: +44.47
Created: 01/01/2008

Comments: 0 | Comment

Recs:
 
Picks
Username P&P Score Call Time Frame Start Date Start Price Today (change) Stock Gain S&P Gain Points Analysis
JDShots 0.22 BUY One to Three Months 11/07/2011 $26.59 $26.22
(-1.35%)
-1.39% +7.03% -8.42 view
wallstreeter 0.23 BUY Six Months to a Year 04/25/2011 $26.12 $26.22
(-1.35%)
+0.38% +1.09% -0.70 view
supratrade1 99.71 BUY One to Three Months 05/20/2009 $18.01 $26.22
(-1.35%)
+45.59% +49.40% -3.81 view
Bob 72.43 BUY Six Months to a Year 01/01/2008 $17.55 $26.22
(-1.35%)
+49.40% -8.05% +57.46
lerouge 13.34 BUY Six Months to a Year 01/01/2008 $22.17 $26.22
(-1.35%)
+18.27% -8.05% +26.32
GoTime 78.30 BUY Six Months to a Year 01/01/2008 $17.68 $26.22
(-1.35%)
+48.30% -8.05% +56.36
drljp 53.37 BUY Six Months to a Year 01/01/2008 $19.22 $26.22
(-1.35%)
+36.42% -8.05% +44.47
Sponsored Links